CIK 0001368514 · Large accelerated filer
ADMA BIOLOGICS, INC.
Sign in to watch- Ticker
- ADMA
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 562590442
- Phone
- (201) 478-5552
- Business address
- C/O ADMA BIOLOGICS, INC., 465 STATE ROUTE 17, RAMSEY, NJ, 07446
- Former names
- R&R ACQUISITION VI, INC
- 4 Open-market buy President & CEO bought 6,400 shares at $8.47 ($54,224)
- 4 Open-market buy Director bought 500 shares at $9.01 ($4,503)
- 4 Open-market buy President & CEO bought 500 shares at an average $9.00 ($4,501)
- 4 Open-market buy Director bought 6,000 shares at $9.16 ($54,961)
- 4 Open-market buy President & CEO bought 2,250 shares at an average $9.15 ($20,584)
- 4 Open-market buy President & CEO bought 1,800 shares at $9.17 ($16,513)
- 4 Open-market buy Chief Financial Officer bought 1,000 shares at an average $9.15 ($9,151)
- 4 Open-market buy President & CEO bought 1,800 shares at $9.18 ($16,529)
- 4 Open-market buy President & CEO bought 3,861 shares at an average $9.21 ($35,572)
- 8-K Event Results of operations
- 10-Q Report Quarterly Report
- 8-K Event Executive or director change
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 8-K Event Regulation FD disclosure
- 8-K Event Results of operations
- 10-Q Report Quarterly Report
- 8-K Event Material agreement · Agreement ended · New debt or obligation · Unregistered share sale · Shareholder vote results
- 8-K Event Regulation FD disclosure
Page 38 of 50 · 1,000 filings